Treasury Secretary Scott Bessent says the United States and China are considering lowering tariffs on “noncritical” items — the consumer goods that fill American shopping carts — as part of the package being assembled around this week’s Trump-Xi summit.
Late on Friday, August 21, the tentative U.S.–Canada trade agreement collapsed, shortly before new tariffs took effect. Market reporting centered on cutting the Section 232 tariff on Canadian primary aluminum to 25 percent, and the concession was poised to reach fabricated aluminum products as well.
The collapse of the U.S.-Canada trade deal is providing a rare glimpse into the secret world of international trade negotiations. Beyond just the insider view, we are being given hope that the mirage of “Fortress North America” can be put to rest.
Mexico’s top trade diplomat, Marcelo Ebrard, was in Washington for several days last week [from Aug. 24 to Aug. 26] but quietly left empty handed on Wednesday.
The collapse of the U.S.-Canada trade negotiation on August 21 drew headlines and criticism aimed at Washington. What the criticism misses is that the deal on the table would have undercut a key plank of U.S. reindustrialization policy and a vital supply line for national security.
President Trump was right to strengthen the Section 232 tariffs on steel and aluminum, and the breakdown of these negotiations should put an end to proposals to weaken them.
The report documents how goods subject to higher U.S. tariffs are routinely rerouted through lower-tariff countries, undermining both tariff enforcement and American manufacturing.
For years, the de minimis loophole allowed foreign shippers to send packages valued at up to $800 into the United States duty-free, tax-free, and with virtually no customs scrutiny — so long as the foreign vendor merely alleged the value was below the threshold.
Today’s Section 232 proclamation secures that foundation, and the entire structure is built to reward one thing: manufacturing in America. Companies investing in U.S. polysilicon, wafer, and cell production are the clear winners, and companies that continue to rely on imports will be at a disadvantage.